Monday 21 January 2013

Endothelin Receptor Antagonists Benefit Pulmonary Arterial Hypertension But Could Have Adverse Effects On The Heart

A research team with the Faculty of Medicine & Dentistry at the University of Alberta reported findings that significantly improve understanding of how widely used drugs in Pulmonary Arterial Hypertension (PAH) affect the heart health of treated patients. The research shows that medications often prescribed for PAH could block the function of an important hormone in the heart, decreasing the strength of contraction of the right heart chambers, a potentially important and yet unrecognized adverse effect... via Health News from Medical News Today Read More Here..

No comments:

Post a Comment